Patents Assigned to FASMAC CO., LTD.
  • Patent number: 12168804
    Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 17, 2024
    Assignees: NIPPN CORPORATION, FASMAC CO., LTD.
    Inventors: Mika Tsuna, Yoshitaka Harada, Yasuhiro Seto, Kazuto Takasaki
  • Patent number: 12163195
    Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.
    Type: Grant
    Filed: November 9, 2023
    Date of Patent: December 10, 2024
    Assignees: NIPPN CORPORATION, FASMAC CO., LTD.
    Inventors: Mika Tsuna, Yoshitaka Harada, Yasuhiro Seto, Kazuto Takasaki
  • Patent number: 12146135
    Abstract: The present invention relates to a method of editing a filamentous fungal genome by direct introduction of a genome editing protein molecule or complex. The method includes three modes. In the first mode, a genome editing protein molecule or complex for a target gene is directly introduced into a cell of an Aspergillus fungus, to edit a gene in the Aspergillus fungal genome. In the second mode, a genome editing protein molecule or complex for a target region in a filamentous fungal genome, and a desired DNA fragment, are directly introduced into a filamentous fungal cell, to knock-in the DNA fragment to a desired target site in the filamentous fungal genome. In the third mode, genome editing protein molecules or complexes for plural target genes are directly introduced into a filamentous fungal cell, to carry out simultaneous editing of the plural genes in the filamentous fungal genome.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: November 19, 2024
    Assignees: NATIONAL RESEARCH INSTITUTE OF BREWING, FASMAC CO., LTD.
    Inventors: Kazuhiro Iwashita, Ken Oda, Kohei Shimamoto, Yusaku Wada
  • Publication number: 20240167104
    Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.
    Type: Application
    Filed: November 9, 2023
    Publication date: May 23, 2024
    Applicants: NIPPN CORPORATION, FASMAC CO., LTD.
    Inventors: Mika TSUNA, Yoshitaka HARADA, Yasuhiro SETO, Kazuto TAKASAKI
  • Patent number: 11705218
    Abstract: In one embodiment, provided are a method for analyzing at least one nucleic acid that can conveniently and highly accurately analyze even a very small number of analyte at least one nucleic acid. In one embodiment, the present invention relates to a method for analyzing at least one nucleic acid, comprising: a library preparation step of preparing a library comprising at least one standard nucleic acid of specific copy number(s) and at least one analyte nucleic acid in a same system; a calibration curve data generation step of generating calibration curve data based on the copy number(s) of the at least one standard nucleic acid of specific copy number(s); and an analyte nucleic acid analysis step of identifying at least one nucleotide sequence of the analyte nucleic acid while identifying the number(s) of the at least one nucleotide sequence of the at least one analyte nucleic acid using the calibration curve data.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: July 18, 2023
    Assignees: Ricoh Company, Ltd., FASMAC CO., LTD.
    Inventors: Yusuke Osaki, Hirotaka Unno, Yudai Kawashima, Michie Hashimoto, Masayuki Yumoto, Satoshi Nakazawa, Yuki Yonekawa, Takahiro Matsudaira, Eri Nishiyama
  • Publication number: 20220170076
    Abstract: A method for manufacturing a device is provided, in which a known quantity of a reagent is reliably immobilized in a reaction field, which can be stored at room temperature, and with which the performance of a real-time PCR apparatus can be correctly evaluated. The method is a method for manufacturing a device having at least one well, in which a specific number of copies of a nucleic acid in the at least one well are immobilized in a reaction field. The method includes a nucleic acid extraction step of extracting the nucleic acid with an enzyme and a drying deactivation step of deactivating the enzyme by drying at 5° C. to 45° C.
    Type: Application
    Filed: November 22, 2021
    Publication date: June 2, 2022
    Applicants: Ricoh Company, Ltd., Fasmac Co., Ltd.
    Inventors: Hirotaka UNNO, Satoshi Nakazawa, Yuuki Yonekawa, Michie Hashimoto, Satoshi Futo, Mari Onishi, Riztyan
  • Publication number: 20210403997
    Abstract: Provided is a device including a well provided in a number of at least one, wherein a nucleic acid having at least one of a full-length nucleotide sequence and a partial nucleotide sequence of rRNA or rDNA is contained in a defined copy number in at least one well of the well, and wherein the defined copy number of the nucleic acid having at least one of a full-length nucleotide sequence and a partial nucleotide sequence of rRNA or rDNA is 1,000 or less.
    Type: Application
    Filed: December 16, 2019
    Publication date: December 30, 2021
    Applicants: Ricoh Company, Ltd., FASMAC CO., LTD.
    Inventors: Michie HASHIMOTO, Hirotaka UNNO, Satoshi NAKAZAWA, Yuki YONEKAWA, Satoshi FUTO, RIZTYAN
  • Publication number: 20210024979
    Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.
    Type: Application
    Filed: December 18, 2017
    Publication date: January 28, 2021
    Applicants: NIPPON FLOUR MILLS CO.,LTD., FASMAC CO., LTD.
    Inventors: Mika TSUNA, Yoshitaka HARADA, Yasuhiro SETO, Kazuto TAKASAKI
  • Publication number: 20200040330
    Abstract: The present invention relates to a method of editing a filamentous fungal genome by direct introduction of a genome editing protein molecule or complex. The method includes three modes. In the first mode, a genome editing protein molecule or complex for a target gene is directly introduced into a cell of an Aspergillus fungus, to edit a gene in the Aspergillus fungal genome. In the second mode, a genome editing protein molecule or complex for a target region in a filamentous fungal genome, and a desired DNA fragment, are directly introduced into a filamentous fungal cell, to knock-in the DNA fragment to a desired target site in the filamentous fungal genome. In the third mode, genome editing protein molecules or complexes for plural target genes are directly introduced into a filamentous fungal cell, to carry out simultaneous editing of the plural genes in the filamentous fungal genome.
    Type: Application
    Filed: August 25, 2017
    Publication date: February 6, 2020
    Applicants: NATIONAL RESEARCH INSTITUTE OF BREWING, FASMAC CO., LTD.
    Inventors: Kazuhiro IWASHITA, Ken ODA, Kohei SHIMAMOTO, Yusaku WADA